Cannabidiol and Cancer Survivors: Utilization and Experiences.

Area of Science:

• Oncology
• Cannabinoid Science
• Patient-Reported Outcomes

Background:

• The effects of cannabidiol (CBD), a cannabis compound, on cancer patients are largely unknown.
• Cancer survivors often experience symptoms that may be alleviated by CBD.

Purpose of the Study:

• To investigate the experiences and attitudes of cancer survivors regarding CBD use.
• To identify the primary reasons for CBD use and perceived benefits among this population.

Main Methods:

• A survey was administered to 1258 cancer survivors across 9 cancer types.
• Data collected included demographics, cancer history, CBD usage patterns, and perceived symptom relief.
• Bivariate logistic regression analyzed differences between CBD users and non-users.

Main Results:

• 18% of cancer survivors reported using CBD post-diagnosis, primarily for pain, sleep difficulties, stress/anxiety/depression, and neuropathy.
• A majority of users reported symptom improvement, with benefits ranging from 60% for neuropathy to 85% for fatigue.
• Nearly half of CBD users discontinued use, most often due to lack of efficacy.

Conclusions:

• Cannabidiol (CBD) is utilized by a significant portion of cancer survivors for symptom management.
• Reported benefits for pain, sleep, distress, and neuropathy suggest potential therapeutic value.
• Clinical trials are essential to rigorously assess the safety and efficacy of CBD in cancer populations.